Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00341120
Other study ID # 999903076
Secondary ID 03-CH-N076
Status Completed
Phase
First received June 19, 2006
Last updated April 4, 2018
Start date January 2, 2003
Est. completion date August 29, 2012

Study information

Verified date August 29, 2012
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is being conducted at the University Hospital of Lund University in Malmo, Sweden, in collaboration with the U.S. National Institute of Child Health and Human Development. The study will try to identify genetic causes of impaired sperm production and male infertility. It will focus on the possible role of the MTHFR and CBS genes, which regulate absorption and metabolism of the vitamin, folate in infertility. If the nutritional intake or metabolism of this vitamin is related to male infertility, then this cause of infertility would be potentially curable.

Fertile and infertile men between 20 and 45 years of age may be eligible for this study. Criteria include the following:

- Fertile men: men whose partners are younger than age 40 and are attending Lund University prenatal clinic; who have fathered one or more pregnancies and who stopped birth control to achieve the present pregnancy; who achieved the present pregnancy in less than 12 months of unprotected intercourse.

- Infertile men: men referred to the Scandian Andrology Centre whose infertility is unexplained, whose partners are younger than age 40 and who have had regular sexual intercourse without contraception for at least 12 months without achieving a pregnancy.

All participants will have the following tests and procedures:

- Complete a questionnaire providing information about their reproductive and medical history and recent dietary history;

- Provide blood samples for analysis of red cell folate, plasma folate, plasma homocysteine, plasma B12, and for genetic evaluation;

- Provide a semen sample for routine analysis, including volume, sperm concentration, sperm motility, and sperm morphology.

In addition, infertile men will undergo a physical examination and review of their medical records.


Description:

It is evident that genetic variation plays a substantial role in the etiology of male infertility. Studies of children fathered through intracytoplasmic sperm injection or ICSI have revealed mutations on the AZF region of the Y chromosome linked to male infertility. Mutations of other genes may also be involved. Candidates would include genes for the androgen receptor, follicle-stimulating hormone, and luteinizing hormone, and genes involved in the regulation of spermatogenesis and sperm motility. Mutations in mitochondrial DNA have been linked to poor sperm motility and raise the possibility that some types of male subfertility may be inherited only through the female line.

We propose to assess the role of folate/homocysteine status and MTHFR and CBS gene variants in infertile men in Sweden with no known cause for their infertility and whose wives/partners appear to be fertile. We propose to perform the study in Sweden since Sweden, unlike the U.S., at present does not mandate the enrichment of flour or other foodstuffs with folate.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date August 29, 2012
Est. primary completion date
Accepts healthy volunteers No
Gender Male
Age group 20 Years to 45 Years
Eligibility - INCLUSION CRITERIA INFERTILE MEN:

Referred to the Scanian Andrology Centre.

Age 20-45.

Partner age less than 40.

Having had regular sexual intercourse without contraception for a year or more without achieving a pregnancy.

EXCLUSION CRITERIA INFERTILE MEN:

Klinefelters syndrome.

Hypogondotropic hypogonadism.

Y-chromosome microdeletion or abnormality.

Other genetic cause for infertility.

Obstructive azoospermia.

Partner with salpingitis.

Partner with polycystic ovarian syndrome.

Partner with disturbance of ovulation.

Partner with endometriosis.

History of cancer.

History of treatment with cytotoxic drugs, irradiation, or sulfasalazopyrine.

History of cryptorchidism.

History of mumps orchitis.

History of vasectomy.

INCLUSION CRITERIA FERTILE MEN:

Partner attending Lund University prenatal clinic.

Age 20-45.

Partner age less than 40.

Having fathered one or more pregnancies.

Having stopped birth control to achieve present pregnancy.

Having achieved present pregnancy in less than 12 months of unprotected intercourse.

EXCLUSION CRITERIA FERTILE MEN:

History of cancer.

History of treatment with cytotoxic drugs, irradiation, or sulfasalazopyrine.

History of cryptorchidism.

History of mumps orchitis.

Having sought or partner having sought treatment or investigation for fertility.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Sweden Malmo University Hospital Malmo

Sponsors (1)

Lead Sponsor Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

Sweden, 

References & Publications (3)

Ford WC. Biological mechanisms of male infertility. Lancet. 2001 Apr 21;357(9264):1223-4. — View Citation

Ma K, Mallidis C, Bhasin S. The role of Y chromosome deletions in male infertility. Eur J Endocrinol. 2000 May;142(5):418-30. Review. — View Citation

Ruiz-Pesini E, Lapeña AC, Díez-Sánchez C, Pérez-Martos A, Montoya J, Alvarez E, Díaz M, Urriés A, Montoro L, López-Pérez MJ, Enríquez JA. Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am J Hum Genet. 2000 Sep;67(3):682-96. Epub 2000 Aug 9. — View Citation

See also
  Status Clinical Trial Phase
Recruiting NCT05503862 - Home Semen Testing in Men Beginning Attempts to Conceive N/A
Recruiting NCT03307655 - Relationship Between Nitric Oxide (NO) in Follicular Fluid and Sperm Fertilization Ability N/A
Withdrawn NCT02839447 - A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0
Completed NCT00975117 - Spermotrend in the Treatment of Male Infertility Phase 3
Completed NCT00756561 - HOP-2A - Intratesticular Hormone Levels N/A
Recruiting NCT04541459 - Validation of New Devices Against Ambient Electromagnetic Radiation Early Phase 1
Completed NCT02889341 - Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility N/A
Not yet recruiting NCT03167008 - Vitamin D Level vs Semen Parameters
Completed NCT02268123 - Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation
Completed NCT01232465 - Impact of Sperm DNA Integrity on In Vitro Cycles N/A
Recruiting NCT00119925 - 'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists" N/A
Completed NCT03552081 - Tobacco and Sperm Genome: Effects of Smoking Cessation N/A
Recruiting NCT05200663 - Efficacy Comparison of Tamoxifen and Tamoxifen With Antioxidants on Semen Quality of Male With Idiopathic Infertility Phase 2
Completed NCT02025270 - MSCs For Treatment of Azoospermic Patients Phase 1/Phase 2
Recruiting NCT06147700 - Identifying Molecular Determinants of Infertility in Men (MODIFY)
Recruiting NCT06188936 - Home Semen Analysis Tests as a Screening Tool for Fertility Patients N/A
Recruiting NCT04200118 - Epigenetic and Genetic Effects in Cancer Patients: Analysis Pre and After Treatment
Terminated NCT02605070 - Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia Phase 3
Completed NCT01407432 - Impact of Folates in the Care of the Male Infertility Phase 3
Completed NCT00596739 - A Study of the Pre- and Post-operative Semen Analyses and Reproductive Hormone Levels of Men Undergoing Weight-reduction Surgery N/A